Stock Scorecard
Stock Summary for Agios Pharmaceuticals Inc (AGIO) - $36.72 as of 9/16/2025 8:21:47 PM EST
Total Score
13 out of 30
Safety Score
55 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for AGIO
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for AGIO
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for AGIO
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for AGIO
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for AGIO (55 out of 100)
| Stock Price Rating (Max of 10) | 8 |
| Historical Stock Price Rating (Max of 10) | 8 |
| Stock Price Trend (Max of 10) | 9 |
| Book Value (Max of 10) | 7 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 3 |
| Analyst Strong Buy Ratings (Max of 5) | 4 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 0 |
| Trading Volume (Max of 10) | 6 |
| Price to Earnings (Max of 10) | 10 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for AGIO
Financial Details for AGIO
Company Overview |
|
|---|---|
| Ticker | AGIO |
| Company Name | Agios Pharmaceuticals Inc |
| Country | USA |
| Description | Agios Pharmaceuticals, Inc., a biopharmaceutical company, is dedicated to drug discovery and development in the field of cellular metabolism and adjacent areas of biology. The company is headquartered in Cambridge, Massachusetts. |
| Sector Name | HEALTHCARE |
| Industry Name | BIOTECHNOLOGY |
| Most Recent Quarter | 6/30/2025 |
| Next Earnings Date | 10/30/2025 |
Stock Price History |
|
| Last Day Price | 36.72 |
| Price 4 Years Ago | 32.87 |
| Last Day Price Updated | 9/16/2025 8:21:47 PM EST |
| Last Day Volume | 577,000 |
| Average Daily Volume | 890,425 |
| 52-Week High | 62.58 |
| 52-Week Low | 23.41 |
| Last Price to 52 Week Low | 56.86% |
Valuation Measures |
|
| Trailing PE | 3.26 |
| Industry PE | 21.46 |
| Sector PE | 40.64 |
| 5-Year Average PE | -4.68 |
| Free Cash Flow Ratio | 26.42 |
| Industry Free Cash Flow Ratio | 13.30 |
| Sector Free Cash Flow Ratio | 29.51 |
| Current Ratio Most Recent Quarter | 14.48 |
| Total Cash Per Share | 1.39 |
| Book Value Per Share Most Recent Quarter | 23.60 |
| Price to Book Ratio | 1.56 |
| Industry Price to Book Ratio | 29.01 |
| Sector Price to Book Ratio | 32.14 |
| Price to Sales Ratio Twelve Trailing Months | 52.28 |
| Industry Price to Sales Ratio Twelve Trailing Months | 42.18 |
| Sector Price to Sales Ratio Twelve Trailing Months | 19.15 |
| Analyst Buy Ratings | 3 |
| Analyst Strong Buy Ratings | 2 |
Share Statistics |
|
| Total Shares Outstanding | 58,102,000 |
| Market Capitalization | 2,133,505,440 |
| Institutional Ownership | 112.91% |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 0.00% |
| Annual Earnings Growth | 291.35% |
| Reported EPS 12 Trailing Months | 11.14 |
| Reported EPS Past Year | -3.48 |
| Reported EPS Prior Year | -6.35 |
| Net Income Twelve Trailing Months | 650,083,000 |
| Net Income Past Year | 673,725,000 |
| Net Income Prior Year | -352,088,000 |
| Quarterly Revenue Growth YOY | 44.60% |
| 5-Year Revenue Growth | -20.91% |
| Operating Margin Twelve Trailing Months | -1,020.00% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 80,871,000 |
| Total Cash Past Year | 76,247,000 |
| Total Cash Prior Year | 88,205,000 |
| Net Cash Position Most Recent Quarter | 80,871,000 |
| Net Cash Position Past Year | 76,247,000 |
| Long Term Debt Past Year | 0 |
| Long Term Debt Prior Year | 0 |
| Total Debt Most Recent Quarter | 0 |
| Equity to Debt Ratio Past Year | 1.00 |
| Equity to Debt Ratio Most Recent Quarter | 1.00 |
| Total Stockholder Equity Past Year | 1,540,956,000 |
| Total Stockholder Equity Prior Year | 811,019,000 |
| Total Stockholder Equity Most Recent Quarter | 1,369,555,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | -409,025,000 |
| Free Cash Flow Per Share Twelve Trailing Months | -7.04 |
| Free Cash Flow Past Year | -391,526,000 |
| Free Cash Flow Prior Year | -297,061,000 |
Options |
|
| Put/Call Ratio | 7.25 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -0.18 |
| MACD Signal | -0.04 |
| 20-Day Bollinger Lower Band | 28.37 |
| 20-Day Bollinger Middle Band | 35.17 |
| 20-Day Bollinger Upper Band | 41.97 |
| Beta | 0.87 |
| RSI | 49.38 |
| 50-Day SMA | 36.93 |
| 150-Day SMA | 32.15 |
| 200-Day SMA | 31.03 |
System |
|
| Modified | 9/16/2025 4:51:04 PM EST |